Nephron Pharmaceuticals Corporation, a South Carolina-based company that develops and produces safe, affordable generic inhalation solutions and suspension products, announced on Thursday that it has named Julie Rameas as its new chief procurement officer.
In the new role, Rameas will manage all strategic sourcing and procurement activities.
Rameas has experience in pharmaceutical, medical device, metal, electronic, aerospace, automotive, and textile manufacturing industries. She has held the position of senior director of Global Strategic Procurement at Thermo Fisher Scientific and served in global director roles at Lear Corporation. She has also worked at BioMerieux, where she led spending on all chemicals, biologics and controlled substances.
Lupin Pharmaceuticals launches Tiotropium Bromide Inhalation Powder, 18mcg/capsule in US
Aurisco announces Yangzhou, China manufacturing site's successful FDA inspection
Teva Pharmaceuticals and Alvotech expand biosimilars partnership in the US
Sandoz to invest USD90m in Biosimilar Technical Development Center in Slovenia
Brenzavvy Now Available for the Treatment of Adults with Type 2 Diabetes
Dr. Reddy's Proposed Rituximab Biosimilar Application Accepted for Review by USFDA, EMA and MHRA
Dr. Reddy's rituximab biosimilar candidate undergoes regulatory review in the US, EU and UK
Grossman Named President and Chief Medical Officer at Coya Therapeutics
Endo International launches first generic version of Merck's Noxafil